Phase 1 Stroke Trial, Recruiting NCT06365099 Sponsor: University of Texas at Austin Condition: Stroke
Back to Stroke

Phase 1 Stroke Trial, Recruiting

NCT06365099
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have some remaining weakness in one arm or hand after a stroke, shown by specific test scores or by the affected hand performing noticeably worse than the unaffected hand on grip or dexterity tasks
  • People who had an ischemic (blocked blood vessel) or hemorrhagic (bleeding) stroke at least 6 months before joining the trial
  • People who are willing and able to give their informed consent to participate
  • People who show a specific type of brain-to-muscle signal (called an MEP+) in the affected arm when the damaged side of the brain is stimulated — meaning some nerve pathway connections are still present (confirm with trial site)

Who may not be able to join:

  • People who have a history of any neurological disease or brain/nerve injury other than stroke
  • People who have a cardiac pacemaker
  • People who have a cochlear implant (hearing device implanted in the ear)
  • People who have a cortical, deep brain, or vagus nerve stimulator implanted
  • People who have cervical spine epidural stimulation
  • People who have a ventriculoperitoneal shunt (a device that drains fluid from the brain)
  • People who have any magnetic metal implants in the head or neck area
  • People who have had a seizure in the last 12 months while taking anti-epilepsy medication
  • People who have previously had a bad reaction to TMS (transcranial magnetic stimulation) or nerve stimulation
  • People who are currently pregnant, suspected to be pregnant, or planning to become pregnant
  • People who have made any changes to their medications within the last month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
University of Texas at Austin
Registry
ClinicalTrials.gov
Start date
2 February 2024
Est. completion
31 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Personalized classifier performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov